
June 10 (Reuters) - Unicycive Therapeutics Inc UNCY.O:
UNICYCIVE PROVIDES UPDATE ON NEW DRUG APPLICATION FOR OXYLANTHANUM CARBONATE TO TREAT HYPERPHOSPHATEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE ON DIALYSIS
UNICYCIVE THERAPEUTICS INC - FDA FINAL DECISION ON OLC NDA EXPECTED BY JUNE 28, 2025
UNICYCIVE THERAPEUTICS INC - FDA IDENTIFIES DEFICIENCIES AT THIRD-PARTY MANUFACTURING VENDOR
UNICYCIVE THERAPEUTICS INC - FDA IDENTIFIES CGMP COMPLIANCE DEFICIENCIES AT THIRD-PARTY VENDOR